Price target
546.530.00 0.00%
The 21 analysts offering 1 year price forecasts for A58 have a max estimate of — and a min estimate of —.
Analyst rating
Based on 25 analysts giving stock ratings to A58 in the past 3 months.
EPS
0.00
Reported
Estimate
Reported
Estimate
Surprise
Revenue
0.00
Reported
Estimate
Reported
Estimate
Surprise
This info isn't a recommendation for what you should personally do, so please don't take the data as investment advice. As with any trade, always look first, then leap. Read more in the Terms of Use.
Frequently Asked Questions
A58 EPS for the last quarter is 9.60 CHF despite the estimation of 9.49 CHF. In the next quarter EPS is expected to reach 8.97 CHF. Track more of ELEVANCE HEALTH IN financials and stay on top of what is up with the company.
In the next quarter ELEVANCE HEALTH IN revenue is expected to reach 38.55 B CHF. Check out ELEVANCE HEALTH IN revenue and earnings and make informed decisions.
According to analysts, A58 price target is 546.53 CHF with a max estimate of 594.44 CHF and a min estimate of 498.79 CHF. Check if this forecast comes true in a year, meanwhile watch ELEVANCE HEALTH IN stock price chart and keep track of the current situation with A58 news and stock market news.
We've gathered opinions of 25 analysts rating A58 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.